Affiliation:
1. Department of Microbiology and Molecular Genetics, University of Vermont, Burlington, VT 05405, USA
2. Department of Molecular Physiology and Biophysics, University of Vermont, Burlington, VT 05405, USA
Abstract
Infective endocarditis (IE), a disease of the endocardial surface of the heart, is usually of bacterial origin and disproportionally affects individuals with underlying structural heart disease. Although IE is typically associated with Gram-positive bacteria, a minority of cases are caused by a group of Gram-negative species referred to as the HACEK group. These species, classically associated with the oral cavity, consist of bacteria from the genera Haemophilus (excluding Haemophilus influenzae), Aggregatibacter, Cardiobacterium, Eikenella, and Kingella. Aggregatibacter actinomycetemcomitans, a bacterium of the Pasteurellaceae family, is classically associated with Aggressive Periodontitis and is also concomitant with the chronic form of the disease. Bacterial colonization of the oral cavity serves as a reservoir for infection at distal body sites via hematological spreading. A. actinomycetemcomitans adheres to and causes disease at multiple physiologic niches using a diverse array of bacterial cell surface structures, which include both fimbrial and nonfimbrial adhesins. The nonfimbrial adhesin EmaA (extracellular matrix binding protein adhesin A), which displays sequence heterogeneity dependent on the serotype of the bacterium, has been identified as a virulence determinant in the initiation of IE. In this chapter, we will discuss the known biochemical, molecular, and structural aspects of this protein, including its interactions with extracellular matrix components and how this multifunctional adhesin may contribute to the pathogenicity of A. actinomycetemcomitans.
Subject
Infectious Diseases,Microbiology (medical),General Immunology and Microbiology,Molecular Biology,Immunology and Allergy
Reference111 articles.
1. Infective endocarditis;Holland;Nat. Rev. Dis. Primers,2016
2. Chambers, S.T., Murdoch, D., Morris, A., Holland, D., Pappas, P., Almela, M., Fernandez-Hidalgo, N., Almirante, B., Bouza, E., and Forno, D. (2013). HACEK infective endocarditis: Characteristics and outcomes from a large, multi-national cohort. PLoS ONE, 8.
3. Infective endocarditis;Cahill;Lancet,2016
4. Recombinant Actinobacillus actinomycetemcomitans cytolethal distending toxin proteins are required to interact to inhibit human cell cycle progression and to stimulate human leukocyte cytokine synthesis;Akifusa;Infect. Immun.,2001
5. Actinobacillus actinomycetemcomitans endocarditis;Paturel;Clin. Microbiol. Infect. Off. Publ. Eur. Soc. Clin. Microbiol. Infect. Dis.,2004